Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.5%
    Check dated 2025-06-19T17:21:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T07:44:28.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-29T05:33:05.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and removed older dates from April 2025 and December 2024. The new version includes more recent dates, indicating a refresh of content.
    Difference
    0.3%
    Check dated 2025-04-30T13:40:50.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The webpage has added new dates for the biopsy procedure, specifically April 15 and April 16, 2025, while removing previous dates from early February 2025.
    Difference
    0.4%
    Check dated 2025-04-23T08:09:21.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a clinical trial involving cabozantinib and nivolumab for treating advanced endometrial cancer, while adding new identifiers and procedural information related to the trial.
    Difference
    54%
    Check dated 2025-04-16T01:07:31.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.